Entellus Medical Stock Price, News & Analysis (NASDAQ:ENTL)

$24.00 -0.01 (-0.04 %)
(As of 02/25/2018 04:00 PM ET)
Previous Close$24.00
Today's Range$23.98 - $24.04
52-Week Range$11.47 - $25.58
Volume517,920 shs
Average Volume115,633 shs
Market Capitalization$617.47 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.02

About Entellus Medical (NASDAQ:ENTL)

Entellus Medical logoEntellus Medical, Inc. is a medical technology company. The Company is focused on delivering patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. Its three core product lines, XprESS Multi-Sinus Dilation Systems, MiniFESS Surgical Instruments, and FocESS Imaging & Navigation, are designed to enable ear, nose and throat (ENT), physicians to perform a range of procedures in the ENT physician office and to simplify operating room-based treatment. The Company's XprESS Multi-Sinus Dilation family of products consists of its XprESS Pro device, its XprESS LoProfile device and its XprESS Ultra device. The MiniFESS family of surgical instruments includes eight devices designed to enable physicians to perform various surgical procedures. The Fiagon Image Guidance System (IGS) consists of a navigation unit, navigation sensor, software instruments and a patient localizer.

Receive ENTL News and Ratings via Email

Sign-up to receive the latest news and ratings for ENTL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:ENTL
CUSIPN/A
Phone763-463-1595

Debt

Debt-to-Equity Ratio0.32%
Current Ratio1.92%
Quick Ratio1.71%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$75.18 million
Price / Sales8.21
Cash FlowN/A
Price / CashN/A
Book Value$1.87 per share
Price / Book12.83

Profitability

Trailing EPS($1.29)
Net Income$-28,710,000.00
Net Margins-31.24%
Return on Equity-47.37%
Return on Assets-27.29%

Miscellaneous

Employees280
Outstanding Shares25,730,000

Entellus Medical (NASDAQ:ENTL) Frequently Asked Questions

What is Entellus Medical's stock symbol?

Entellus Medical trades on the NASDAQ under the ticker symbol "ENTL."

How were Entellus Medical's earnings last quarter?

Entellus Medical Inc (NASDAQ:ENTL) announced its quarterly earnings data on Thursday, November, 3rd. The medical technology company reported ($0.50) earnings per share for the quarter, missing analysts' consensus estimates of ($0.37) by $0.13. The medical technology company earned $17.90 million during the quarter, compared to analyst estimates of $17.93 million. Entellus Medical had a negative net margin of 31.24% and a negative return on equity of 47.37%. The firm's revenue for the quarter was up 20.9% on a year-over-year basis. During the same period in the prior year, the company posted ($0.32) earnings per share. View Entellus Medical's Earnings History.

Where is Entellus Medical's stock going? Where will Entellus Medical's stock price be in 2018?

3 brokers have issued twelve-month price objectives for Entellus Medical's stock. Their forecasts range from $17.00 to $21.00. On average, they expect Entellus Medical's stock price to reach $19.00 in the next twelve months. View Analyst Ratings for Entellus Medical.

Who are some of Entellus Medical's key competitors?

Who are Entellus Medical's key executives?

Entellus Medical's management team includes the folowing people:

  • Robert S. White, President, Chief Executive Officer, Director (Age 55)
  • Brent A. Moen, Chief Financial Officer, Corporate Secretary (Age 49)
  • Michael H. Rosenthal, Chief Operating Officer (Age 43)
  • Jonelle R. Burnham, Chief Compliance Officer, Vice President, General Counsel (Age 46)
  • Stephen R. Paidosh, Vice President, Operations (Age 54)
  • Thomas D. Williamson, Vice President - Sales (Age 42)
  • Kevin L. Mensink, Vice President of Marketing (Age 44)
  • Martha J. Christian, Vice President, Reimbursement (Age 53)
  • Timothy B. Petrick, Vice President, Research and Development (Age 49)
  • Brian E. Farley, Non-Executive Chairman of the Board (Age 59)

When did Entellus Medical IPO?

(ENTL) raised $70 million in an initial public offering (IPO) on Friday, January 30th 2015. The company issued 4,400,000 shares at a price of $15.00-$17.00 per share. BofA Merrill Lynch and Piper Jaffray acted as the underwriters for the IPO and William Blair and Canaccord Genuity were co-managers.

Who owns Entellus Medical stock?

Entellus Medical's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Sand Grove Capital Management LLP (5.30%), ArrowMark Colorado Holdings LLC (3.83%), BlackRock Inc. (2.63%), Archon Capital Management LLC (2.23%), Gabelli Funds LLC (1.35%) and Water Island Capital LLC (0.77%). Company insiders that own Entellus Medical stock include Brent Moen, Brian E Farley, James D Surek, Joshua J Baltzell, Karen E Peterson, Kevin L Mensink, Life Sciences Fu International, Margaret A Boiano, Robert S White, Stephen R Paidosh, Thomas P Williamson and Timothy B Petrick. View Institutional Ownership Trends for Entellus Medical.

Who sold Entellus Medical stock? Who is selling Entellus Medical stock?

Entellus Medical's stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., First Manhattan Co., Granite Point Capital Management L.P., Endurant Capital Management LP, Keybank National Association OH and Cypress Capital Management LLC WY. Company insiders that have sold Entellus Medical company stock in the last year include Brent Moen, Brian E Farley, Karen E Peterson, Kevin L Mensink, Robert S White, Stephen R Paidosh, Thomas P Williamson and Timothy B Petrick. View Insider Buying and Selling for Entellus Medical.

Who bought Entellus Medical stock? Who is buying Entellus Medical stock?

Entellus Medical's stock was purchased by a variety of institutional investors in the last quarter, including Sand Grove Capital Management LLP, Gabelli Funds LLC, ArrowMark Colorado Holdings LLC, Water Island Capital LLC, Havens Advisors LLC, BlackRock Inc., Gardner Lewis Asset Management L P and OppenheimerFunds Inc.. Company insiders that have bought Entellus Medical stock in the last two years include Brent Moen, Joshua J Baltzell and Robert S White. View Insider Buying and Selling for Entellus Medical.

How do I buy Entellus Medical stock?

Shares of Entellus Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Entellus Medical's stock price today?

One share of Entellus Medical stock can currently be purchased for approximately $24.00.

How big of a company is Entellus Medical?

Entellus Medical has a market capitalization of $617.47 million and generates $75.18 million in revenue each year. The medical technology company earns $-28,710,000.00 in net income (profit) each year or ($1.29) on an earnings per share basis. Entellus Medical employs 280 workers across the globe.

How can I contact Entellus Medical?

Entellus Medical's mailing address is 3600 HOLLY LANE NORTH SUITE 40, PLYMOUTH MN, 55447. The medical technology company can be reached via phone at 763-463-1595.


MarketBeat Community Rating for Entellus Medical (ENTL)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  169 (Vote Outperform)
Underperform Votes:  122 (Vote Underperform)
Total Votes:  291
MarketBeat's community ratings are surveys of what our community members think about Entellus Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Entellus Medical (NASDAQ:ENTL) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.002.332.43
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $19.00$18.00$20.80$21.83
Price Target Upside: 20.80% downside24.97% downside10.82% upside25.91% upside

Entellus Medical (NASDAQ:ENTL) Consensus Price Target History

Price Target History for Entellus Medical (NASDAQ:ENTL)

Entellus Medical (NASDAQ:ENTL) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/8/2017William BlairDowngradeOutperform -> Market PerformMediumView Rating Details
10/17/2017Canaccord GenuityReiterated RatingHold$17.00N/AView Rating Details
8/22/2017Piper Jaffray CompaniesReiterated RatingBuy$21.00LowView Rating Details
2/22/2017Bank of AmericaDowngradeBuy -> Underperform$16.00N/AView Rating Details
2/22/2017BTIG ResearchDowngradeBuy -> NeutralN/AView Rating Details
12/6/2016GuggenheimInitiated CoverageBuy$25.00N/AView Rating Details
11/4/2016Deutsche BankReiterated RatingBuy$25.00 -> $26.00N/AView Rating Details
(Data available from 2/25/2016 forward)

Earnings

Entellus Medical (NASDAQ:ENTL) Earnings History and Estimates Chart

Earnings by Quarter for Entellus Medical (NASDAQ:ENTL)

Entellus Medical (NASDAQ ENTL) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2017Q3 2017($0.51)($0.49)$22.97 million$23.33 millionViewN/AView Earnings Details
8/3/2017Q2 2017($0.34)($0.37)$21.87 million$22.10 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.44)($0.40)$19.61 million$19.11 millionViewListenView Earnings Details
2/21/2017Q4 2016($0.33)($0.39)$21.58 million$21.70 millionViewListenView Earnings Details
11/3/2016Q3($0.37)($0.50)$17.93 million$17.90 millionViewListenView Earnings Details
8/3/2016Q2($0.35)($0.27)$18.48 million$18.73 millionViewListenView Earnings Details
5/4/2016Q1($0.47)($0.37)$16.34 million$16.90 millionViewListenView Earnings Details
2/24/2016Q4($0.26)($0.27)$17.52 million$18.07 millionViewListenView Earnings Details
11/5/2015Q315($0.25)($0.32)$14.19 million$14.80 millionViewListenView Earnings Details
8/6/2015Q215($0.20)($0.15)$15.00 million$15.20 millionViewListenView Earnings Details
5/7/2015Q1 2015($0.48)($0.35)$13.02 million$13.50 millionViewN/AView Earnings Details
3/17/2015Q4 2014($0.73)$14.46 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Entellus Medical (NASDAQ:ENTL) Earnings Estimates

2018 EPS Consensus Estimate: ($1.15)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.34)($0.34)($0.34)
Q2 20181($0.27)($0.27)($0.27)
Q3 20181($0.30)($0.30)($0.30)
Q4 20181($0.24)($0.24)($0.24)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Entellus Medical (NASDAQ:ENTL)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Entellus Medical (NASDAQ ENTL) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 7.70%
Institutional Ownership Percentage: 83.44%
Insider Trades by Quarter for Entellus Medical (NASDAQ:ENTL)
Insider Trades by Quarter for Entellus Medical (NASDAQ:ENTL)

Entellus Medical (NASDAQ ENTL) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/8/2018Thomas P. WilliamsonVPSell2,449$24.08$58,971.92View SEC Filing  
1/5/2018Brent MoenCFOSell735$24.01$17,647.35View SEC Filing  
1/5/2018Robert S. WhiteInsiderSell3,471$24.01$83,338.71View SEC Filing  
1/5/2018Thomas P. WilliamsonVPSell968$24.01$23,241.68View SEC Filing  
12/7/2017Brian E. FarleyDirectorSell101,319$23.85$2,416,458.15View SEC Filing  
10/20/2017Kevin L. MensinkVPSell2,500$19.00$47,500.00View SEC Filing  
10/16/2017Kevin L. MensinkVPSell10,000$18.29$182,900.00View SEC Filing  
10/9/2017Karen E PetersonVPSell650$20.17$13,110.50View SEC Filing  
10/4/2017Brian E FarleyDirectorSell40,000$19.78$791,200.00View SEC Filing  
10/4/2017Timothy B PetrickVPSell2,000$20.01$40,020.00View SEC Filing  
10/3/2017Brian E. FarleyDirectorSell6,028$19.17$115,556.76View SEC Filing  
10/2/2017Brian E. FarleyDirectorSell3,972$19.10$75,865.20View SEC Filing  
9/22/2017Timothy B. PetrickVPSell2,000$18.00$36,000.00View SEC Filing  
9/13/2017Stephen R. PaidoshVPSell25,000$17.54$438,500.00View SEC Filing  
5/8/2017Brent MoenCFOBuy6,100$12.21$74,481.00View SEC Filing  
5/8/2017Joshua J BaltzellDirectorBuy1,600$12.34$19,744.002,850View SEC Filing  
5/8/2017Robert S. WhiteInsiderBuy10,000$12.24$122,400.00View SEC Filing  
1/31/2017Life Sciences Fu InternationalMajor ShareholderSell533,077$17.00$9,062,309.00View SEC Filing  
1/13/2017Brian E FarleyDirectorSell14,019$20.14$282,342.66430,562View SEC Filing  
1/13/2017Karen E. PetersonVPSell10,000$20.13$201,300.00View SEC Filing  
1/10/2017Brian E FarleyDirectorSell9,842$19.11$188,080.62449,423View SEC Filing  
1/10/2017Karen E. PetersonVPSell9,840$19.11$188,042.40View SEC Filing  
1/4/2017Brian E FarleyDirectorSell20,158$18.74$377,760.92454,581View SEC Filing  
1/4/2017Karen E PetersonVPSell10,160$18.74$190,398.4043,384View SEC Filing  
12/6/2016Brian E FarleyDirectorSell15,000$18.57$278,550.00484,581View SEC Filing  
11/23/2016Brian E FarleyDirectorSell5,000$19.00$95,000.00494,581View SEC Filing  
11/18/2016Brian E FarleyDirectorSell10,000$18.30$183,000.00509,581View SEC Filing  
10/13/2016Margaret A. BoianoVPSell11,103$20.01$222,171.03View SEC Filing  
10/5/2016Brian E FarleyDirectorSell30,000$22.26$667,800.00514,581View SEC Filing  
9/8/2016James D SurekVPSell10,000$18.71$187,100.0095,031View SEC Filing  
9/2/2016Brian E FarleyDirectorSell11,078$18.62$206,272.36544,581View SEC Filing  
9/1/2016Brian E FarleyDirectorSell17,006$19.33$328,725.98560,265View SEC Filing  
9/1/2016Kevin L. MensinkVPSell8,000$18.39$147,120.00View SEC Filing  
8/1/2016Kevin L MensinkVPSell8,100$17.63$142,803.008,000View SEC Filing  
7/18/2016Timothy B. PetrickVPSell3,000$18.15$54,450.00View SEC Filing  
2/11/2016Karen E PetersonInsiderSell5,000$16.00$80,000.0058,384View SEC Filing  
2/4/2016Karen E PetersonInsiderSell10,000$17.00$170,000.0063,384View SEC Filing  
9/17/2015Brian E. FarleyChairmanSell5,484$22.00$120,648.00572,665View SEC Filing  
9/15/2015Brian E. FarleyChairmanSell27,619$22.18$612,589.42578,149View SEC Filing  
9/14/2015Brian E. FarleyChairmanSell21,187$22.15$469,292.05578,149View SEC Filing  
9/2/2015James D SurekVPSell15,000$21.27$319,050.00105,031View SEC Filing  
8/31/2015James D. SurekVPSell5,000$22.29$111,450.00120,031View SEC Filing  
2/3/2015Robert S WhiteCOOBuy5,882$17.00$99,994.00View SEC Filing  
2/3/2015Shawn MccormickDirectorBuy2,941$17.00$49,997.00View SEC Filing  
2/3/2015Woodlands Health Venture EssexMajor ShareholderBuy352,941$17.00$5,999,997.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Entellus Medical (NASDAQ ENTL) News Headlines

Source:
DateHeadline
Entellus Medical (ENTL) Rating Lowered to Strong Sell at BidaskClubEntellus Medical (ENTL) Rating Lowered to Strong Sell at BidaskClub
www.americanbankingnews.com - February 17 at 1:02 PM
Entellus Medical (ENTL) to Release Earnings on MondayEntellus Medical (ENTL) to Release Earnings on Monday
www.americanbankingnews.com - February 12 at 3:02 AM
New Research Coverage Highlights Atara Biotherapeutics, SPX, Entellus Medical, Columbus McKinnon, NantKwest, and Merrimack Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 2018New Research Coverage Highlights Atara Biotherapeutics, SPX, Entellus Medical, Columbus McKinnon, NantKwest, and Merrimack Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 2018
finance.yahoo.com - February 6 at 9:07 AM
Entellus Medical Inc (ENTL) Given Consensus Rating of "Hold" by BrokeragesEntellus Medical Inc (ENTL) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - February 6 at 5:10 AM
-$0.44 EPS Expected for Entellus Medical Inc (ENTL) This Quarter-$0.44 EPS Expected for Entellus Medical Inc (ENTL) This Quarter
www.americanbankingnews.com - February 4 at 3:16 AM
Entellus Medical (ENTL) Stock Rating Lowered by Zacks Investment ResearchEntellus Medical (ENTL) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - January 24 at 10:50 PM
$28.75 Million in Sales Expected for Entellus Medical Inc (ENTL) This Quarter$28.75 Million in Sales Expected for Entellus Medical Inc (ENTL) This Quarter
www.americanbankingnews.com - January 20 at 2:04 PM
The Law Offices of Vincent Wong Notifies Investors of a Complaint on Behalf of Entellus Medical, Inc. Shareholders Concerning the Sale of the Company to Stryker Corporation ...The Law Offices of Vincent Wong Notifies Investors of a Complaint on Behalf of Entellus Medical, Inc. Shareholders Concerning the Sale of the Company to Stryker Corporation ...
www.businesswire.com - January 18 at 10:57 AM
Entellus Medical Inc (ENTL) Expected to Announce Earnings of -$0.45 Per ShareEntellus Medical Inc (ENTL) Expected to Announce Earnings of -$0.45 Per Share
www.americanbankingnews.com - January 18 at 5:06 AM
Entellus Medical Inc (ENTL) Sees Large Decline in Short InterestEntellus Medical Inc (ENTL) Sees Large Decline in Short Interest
www.americanbankingnews.com - January 15 at 4:40 AM
Entellus Medical Inc (ENTL) Given Average Recommendation of "Hold" by BrokeragesEntellus Medical Inc (ENTL) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - January 12 at 8:02 AM
Entellus Medical Inc (ENTL) CFO Brent Moen Sells 735 SharesEntellus Medical Inc (ENTL) CFO Brent Moen Sells 735 Shares
www.americanbankingnews.com - January 9 at 7:56 PM
Entellus Medical Inc (ENTL) VP Sells $23,241.68 in StockEntellus Medical Inc (ENTL) VP Sells $23,241.68 in Stock
www.americanbankingnews.com - January 9 at 7:56 PM
Robert S. White Sells 3,471 Shares of Entellus Medical Inc (ENTL) StockRobert S. White Sells 3,471 Shares of Entellus Medical Inc (ENTL) Stock
www.americanbankingnews.com - January 9 at 7:16 PM
Entellus Medical Inc (ENTL) VP Thomas P. Williamson Sells 2,449 SharesEntellus Medical Inc (ENTL) VP Thomas P. Williamson Sells 2,449 Shares
www.americanbankingnews.com - January 9 at 7:16 PM
ACT NOW: Monteverde & Associates PC Announces An Investigation Of Entellus Medical, Inc. - ENTLACT NOW: Monteverde & Associates PC Announces An Investigation Of Entellus Medical, Inc. - ENTL
finance.yahoo.com - January 8 at 4:59 PM
Entellus (ENTL) Nears 52-Week High: Whats Driving It?Entellus (ENTL) Nears 52-Week High: What's Driving It?
www.zacks.com - January 3 at 4:55 PM
 Brokerages Expect Entellus Medical Inc (ENTL) Will Post Quarterly Sales of $28.75 Million Brokerages Expect Entellus Medical Inc (ENTL) Will Post Quarterly Sales of $28.75 Million
www.americanbankingnews.com - January 3 at 8:30 AM
Zacks: Brokerages Anticipate Entellus Medical Inc (ENTL) to Post -$0.45 EPSZacks: Brokerages Anticipate Entellus Medical Inc (ENTL) to Post -$0.45 EPS
www.americanbankingnews.com - January 1 at 11:22 AM
Entellus Medical Inc (ENTL) Sees Large Decrease in Short InterestEntellus Medical Inc (ENTL) Sees Large Decrease in Short Interest
www.americanbankingnews.com - December 31 at 3:14 AM
Lifshitz & Miller LLP Announces Investigation of Atlantic Coast Financial Corporation, Bazaarvoice, Inc., Buffalo Wild Wings, Inc., Entellus Medical, Inc., General Cable Corporation, Quality Systems, Inc., and Shopify Inc.Lifshitz & Miller LLP Announces Investigation of Atlantic Coast Financial Corporation, Bazaarvoice, Inc., Buffalo Wild Wings, Inc., Entellus Medical, Inc., General Cable Corporation, Quality Systems, Inc., and Shopify Inc.
finance.yahoo.com - December 28 at 3:36 PM
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders - ENTLINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders - ENTL
finance.yahoo.com - December 28 at 12:12 PM
Entellus Medical Inc (ENTL) Given Consensus Recommendation of "Hold" by BrokeragesEntellus Medical Inc (ENTL) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - December 18 at 8:44 AM
Entellus Medical (ENTL) Rating Increased to C- at TheStreetEntellus Medical (ENTL) Rating Increased to C- at TheStreet
www.americanbankingnews.com - December 16 at 9:36 AM
 Brokerages Anticipate Entellus Medical Inc (ENTL) Will Post Earnings of -$0.45 Per Share Brokerages Anticipate Entellus Medical Inc (ENTL) Will Post Earnings of -$0.45 Per Share
www.americanbankingnews.com - December 15 at 7:08 PM
The Law Offices of Vincent Wong Notifies Investors of an Investigation of Entellus Medical, Inc. Concerning the Sale of the Company to Stryker CorporationThe Law Offices of Vincent Wong Notifies Investors of an Investigation of Entellus Medical, Inc. Concerning the Sale of the Company to Stryker Corporation
finance.yahoo.com - December 13 at 5:02 PM
Entellus Medical (ENTL) Upgraded to Hold by ValuEngineEntellus Medical (ENTL) Upgraded to Hold by ValuEngine
www.americanbankingnews.com - December 9 at 5:08 PM
Entellus Medical IncEntellus Medical Inc
www.bloomberg.com - December 9 at 4:48 PM
Entellus Medical (ENTL) to be Acquired by Stryker (SYK) for $24 Per Share in CashEntellus Medical (ENTL) to be Acquired by Stryker (SYK) for $24 Per Share in Cash
www.streetinsider.com - December 9 at 4:48 PM
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to ShareholdersINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders
finance.yahoo.com - December 8 at 4:48 PM
Entellus Medical (ENTL) Cut to Hold at William BlairEntellus Medical (ENTL) Cut to Hold at William Blair
www.americanbankingnews.com - December 8 at 2:34 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders – ENTLSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders – ENTL
finance.yahoo.com - December 8 at 9:59 AM
ETFs with exposure to Entellus Medical, Inc. : December 7, 2017ETFs with exposure to Entellus Medical, Inc. : December 7, 2017
finance.yahoo.com - December 8 at 9:59 AM
Is There Now An Opportunity In Entellus Medical Inc (ENTL)?Is There Now An Opportunity In Entellus Medical Inc (ENTL)?
finance.yahoo.com - December 8 at 9:59 AM
Entellus Medical, Inc. breached its 50 day moving average in a Bullish Manner : ENTL-US : December 8, 2017Entellus Medical, Inc. breached its 50 day moving average in a Bullish Manner : ENTL-US : December 8, 2017
finance.yahoo.com - December 8 at 9:59 AM
Brian E. Farley Sells 101,319 Shares of Entellus Medical Inc (ENTL) StockBrian E. Farley Sells 101,319 Shares of Entellus Medical Inc (ENTL) Stock
www.americanbankingnews.com - December 7 at 5:26 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per ...SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per ...
www.businesswire.com - December 7 at 5:13 PM
Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in CashEntellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in Cash
finance.yahoo.com - December 7 at 10:20 AM
Stryker announces definitive agreement to acquire EntellusStryker announces definitive agreement to acquire Entellus
finance.yahoo.com - December 7 at 10:20 AM
Entellus Medical to be acquired by Stryker for $24 a share in cashEntellus Medical to be acquired by Stryker for $24 a share in cash
finance.yahoo.com - December 7 at 10:20 AM
Stryker to buy Entellus Medical for $662 mlnStryker to buy Entellus Medical for $662 mln
finance.yahoo.com - December 7 at 10:20 AM
Stryker beefs up ENT business with $662 mln Entellus buyStryker beefs up ENT business with $662 mln Entellus buy
finance.yahoo.com - December 7 at 10:20 AM
-$0.45 EPS Expected for Entellus Medical Inc (ENTL) This Quarter-$0.45 EPS Expected for Entellus Medical Inc (ENTL) This Quarter
www.americanbankingnews.com - November 27 at 11:26 AM
Entellus Medical, Inc. (ENTL) Given Consensus Recommendation of "Hold" by BrokeragesEntellus Medical, Inc. (ENTL) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 23 at 10:10 AM
ETFs with exposure to Entellus Medical, Inc. : November 21, 2017ETFs with exposure to Entellus Medical, Inc. : November 21, 2017
finance.yahoo.com - November 21 at 6:31 PM
Entellus Medical to Participate in Upcoming Investor ConferencesEntellus Medical to Participate in Upcoming Investor Conferences
finance.yahoo.com - November 14 at 6:46 PM
Anthem Inc. Issues Positive Coverage Decision for Balloon Sinus DilationAnthem Inc. Issues Positive Coverage Decision for Balloon Sinus Dilation
finance.yahoo.com - November 13 at 11:32 AM
Entellus Medical, Inc. :ENTL-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017Entellus Medical, Inc. :ENTL-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017
finance.yahoo.com - November 13 at 11:32 AM
ETFs with exposure to Entellus Medical, Inc. : November 10, 2017ETFs with exposure to Entellus Medical, Inc. : November 10, 2017
finance.yahoo.com - November 10 at 12:53 PM
Entellus Medical, Inc. (ENTL) Expected to Post Quarterly Sales of $28.89 MillionEntellus Medical, Inc. (ENTL) Expected to Post Quarterly Sales of $28.89 Million
www.americanbankingnews.com - November 10 at 3:08 AM

SEC Filings

Entellus Medical (NASDAQ:ENTL) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Entellus Medical (NASDAQ:ENTL) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Entellus Medical (NASDAQ ENTL) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.